LYRA THERAPEUTICS INC vs. NVIDIA Corporation
NVIDIA Corporation (NVDA) comes out ahead, leading on 3 of 4 compared factors.
Size & Scale
| LYRA | NVDA | |
|---|---|---|
| Market Cap | — | $5.37 trillion |
| Revenue (TTM) | $398,000 | $302.97 billion |
| Net Income (TTM) | $-28,919,000 | $192.88 billion |
NVDA leads on 2 of 2 size & scale factors.
Valuation
| LYRA | NVDA | |
|---|---|---|
| P/E Ratio | — | 28.10 |
| Price / Book | — | 23.44 |
| Price / Sales | — | 17.72 |
LYRA and NVDA split the valuation factors evenly.
Profitability
| LYRA | NVDA | |
|---|---|---|
| Net Margin | -7266.08% | 63.66% |
| Return on Equity | 269.84% | 84.23% |
LYRA and NVDA split the profitability factors evenly.
Dividend
| LYRA | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.45% |
| Payout Ratio | — | 12.64 |
LYRA and NVDA split the dividend factors evenly.
Risk & Sentiment
| LYRA | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
LYRA and NVDA split the risk & sentiment factors evenly.
Dig deeper: LYRA overview, LYRA financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.